This suggests that in addition to cognitive damage, this animal model of AD also reflects the disruption of the central insulin signaling pathway, and DSS intervention may affect the expression of IRS1 and GSK3β in the central glucose metabolism pathway. The gene discussed is IRS1; the disease is Alzheimer disease.